Renis H E
Arch Virol. 1977;54(1-2):85-93. doi: 10.1007/BF01314381.
Inoculation of hamsters with influenza virus [A/PR/8/34 HON 1] produces an inapparent infection which can be monitored by virus titrations of nasal washes or of homogenates prepared from trachea or lung. Antibody can be detected in the serum within 7 days following virus inoculation. Hamsters previously infected were found to be resistant to challenge with the same virus. The utility of this model for evaluating anti-influenza drugs was demonstrated with two compounds. Calcium elenolate, a virucidal agent, reduced the virus titers of nasal washes when the drug was given as nose drops near the time of virus inoculation so as to affect high drug concentrations in the nasal passages. Virazole, an inhibitor of virus replication, reduced the virus titers of the nasal washes when multiple drug treatments were given as nose drops in an effort to provide drug during the time of virus replication. The model described may provide a useful means of evaluating potential antiviral during candidates inasmuch as the drug can be delivered directly into the nasal passages in a non-fatal influenza infection in a convenient laboratory animal.
用流感病毒[A/PR/8/34 HON 1]接种仓鼠会产生隐性感染,这种感染可通过对鼻洗液或由气管或肺制备的匀浆进行病毒滴定来监测。在病毒接种后7天内可在血清中检测到抗体。发现先前感染的仓鼠对相同病毒的攻击具有抵抗力。用两种化合物证明了该模型在评估抗流感药物方面的实用性。乙磺烯酸钙是一种杀病毒剂,当在病毒接种时以滴鼻剂形式给药时,可降低鼻洗液中的病毒滴度,从而在鼻道中产生高药物浓度。病毒唑是一种病毒复制抑制剂,当多次以滴鼻剂形式给药以在病毒复制期间提供药物时,可降低鼻洗液中的病毒滴度。所描述的模型可能提供一种有用的方法来评估潜在的抗病毒候选药物,因为在方便的实验动物的非致命性流感感染中,药物可以直接递送到鼻道中。